Pacira Pharma (PCRX) Tops Q2 EPS by 17c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus

Go back to Pacira Pharma (PCRX) Tops Q2 EPS by 17c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
PACIRA (NASDAQ: PCRX) Delayed: 22.71 --0 (-0%)
Previous Close $22.71    52 Week High $80.25 
Open $22.71    52 Week Low $30.25 
Day High $22.71    P/E N/A 
Day Low $22.71    EPS $-2.08 
Volume 859